About Epistaxis (Nosebleed)

Overview

Epistaxis, commonly known as a nosebleed, refers to bleeding from the nose. It occurs when the blood vessels in the nasal passage are damaged. Nosebleeds can be categorized as anterior (front) or posterior (back), depending on where the tissue damage occurs. Anterior nosebleeds are more common and usually do not require medical treatment. Posterior nosebleeds are less common and may require medical attention. Nosebleeds can happen to people of all ages but are more common in children and older adults. They are also more likely to occur in individuals with a history of bleeding disorders, genetic bleeding conditions, those taking blood-thinning medications, or those using medications through the nose. Nosebleeds can be caused by various factors, such as dryness or injury to the nasal tissues.

Causes and Risk Factors

The pathophysiologic causes of epistaxis (nosebleed) include:

Facial injury
Physical or chemical mucosal irritation
Allergic rhinitis
Infectious rhinitis
Nasal tumors
Temperature and humidity changes
Systemic conditions such as hypertension, coagulation disorders, diabetes, heart failure, anemia, and liver disorders
Medication use, including anticoagulants and intranasal medications

The non-modifiable (things that cannot be changed) risk factors of epistaxis (nosebleed) include:

Age: Epistaxis is more common in children younger than 10 and adults between the ages of 70 and 79.
Genetic conditions: Hemophilia and Hereditary Hemorrhagic Telangiectasia (HHT) are genetic disorders that can cause recurrent nosebleeds.

The modifiable (things that can be changed) risk factors of Epistaxis (Nosebleed) include:

Nose picking: This is the most common cause of nosebleeds.
Nasal irritants: Exposure to nasal irritants like smoke, chemicals, or dry air can increase the risk of nosebleeds.
Nasal/facial oxygen use: Oxygen therapy or wearing nasal masks for certain medical conditions can contribute to nosebleeds.
Medication use: Blood-thinning medications and intranasal medications can increase the likelihood of nosebleeds.

It's important to note that these risk factors may vary from person to person. If you experience frequent nosebleeds or have concerns, it's best to consult with a healthcare professional for personalized advice.

Symptoms

The most common early symptom of epistaxis (nosebleed) is bleeding from the nose, typically following damage to the blood vessels in the nasal passage. Other common symptoms that may occur with later stages, progression, or higher severity of epistaxis include:

Recurrent nosebleeds: Epistaxis can be recurrent, with bleeding episodes happening repeatedly.
Unpredictable bleeding: Nosebleeds can occur unexpectedly and may happen even at night when the person is asleep.
Bleeding intensity: The intensity of bleeding may vary, with some episodes being mild and others more severe.
Difficulty in stopping bleeding: In severe cases, it may be challenging to stop the bleeding without medical intervention.
Increased frequency: As the condition progresses, the frequency of nosebleeds may increase.
Longer duration: Nosebleeds may last for a longer duration as the severity of epistaxis worsens.

It's important to note that these symptoms can vary from person to person. If you experience frequent or severe nosebleeds, it is advisable to seek medical attention for proper evaluation and management.

Diagnosis

To diagnose and determine severity of epistaxis, the following examinations, tests, and procedures are commonly performed:

Diagnosis:

Physical examination: A doctor will examine your nose and may use a nasal speculum to look inside your nasal passages.
Medical history: Your doctor will ask about your symptoms, medical history, and any medications you are taking.
Blood testing: Blood tests may be obtained to check for blood clotting abnormalities.
Curaao criteria: The Curaao criteria are used to diagnose Hereditary Hemorrhagic Telangiectasia (HHT), a condition associated with recurrent nosebleeds. These criteria include recurrent epistaxis, cutaneous/mucosal telangiectasia, visceral involvement, and a family history of HHT.
Genetic testing: Genetic testing may be done to confirm a diagnosis of hemophilia and HHT in some cases.

Severity assessment:

Epistaxis Severity Score (ESS): The ESS is used to measure the severity of nosebleeds based on factors such as frequency and duration. A higher score indicates more severe nosebleeds.

It's important to note that the specific examinations, tests, and procedures may vary depending on individual cases and the suspected underlying cause of epistaxis. It is recommended to consult with a healthcare professional for an accurate diagnosis and appropriate management.

Treatment Options

The goals of treatment for epistaxis are to identify the bleeding sites and achieve immediate and effective hemostasis (stopping the bleeding). Here are the different types of treatments and how they work to achieve these goals:

Medication types:

Anti-inflammatory therapy: This helps reduce inflammation in the nasal passages, which can contribute to nosebleeds.

Therapies:

Nasal cavity exploration: Careful examination of the nasal cavity helps identify the exact location of bleeding sites.
Electrocautery: This procedure uses heat to cauterize (seal) blood vessels, stopping the bleeding.
Packing: Nasal packing involves placing a material (such as gauze or an inflatable balloon) into the nasal cavity to apply pressure and stop the bleeding.

Health behavior changes:

Care of mucous membranes: Patients can prevent nosebleeds by regularly moisturizing their nasal passages with a soft nose ointment or oil and by not putting their fingers in their noses.

It's important to note that these treatments should be performed under medical supervision. Medication dosing may be affected by many factors. Check with your health care professional about dosing for your individual situation. Side effects can occur. Check with your health care professional or read the information provided with your medication for side effect information.